# Organigram Global

Organigram Global is an Asset Manager based in Toronto, Canada.

## Overview

- **Organization type:** Asset Manager
- **Headquarters:** Toronto, Canada
- **Region:** North America
- **Address:** Toronto, ON, Canada
- **Assets under management:** Undisclosed
- **Website:** www.organigram.ca
- **LinkedIn:** https://www.linkedin.com/company/organigram

## Regulatory record

- **Reports private funds:** No

## About

Organigram is a global leader in cannabis, renowned for its innovation, quality, and trusted portfolio of brands. It redefines the cannabis industry through innovation, beloved consumer brands, and a growing international presence. The company pushes boundaries in cultivation and product development using a scientific approach and cutting-edge technology, and strategically invests in and partners with companies to extend its reach beyond Canada.

## Sectors

- Cannabis
- Consumer Goods

## Offices

- Moncton, NB
- Lac-Supérieur, QC
- Winnipeg, MB
- Aylmer, ON
- London, ON

## People

- James Yamanaka — Chief Executive Officer
- Beena Goldenberg — Chief Executive Officer
- Greg Guyatt — Chief Financial Officer
- Tim Emberg — President of Organigram Canada
- Paolo de Luca — Chief Strategy Officer
- Helen Martin — Chief Legal Officer
- Valerie Rother — Chief People Officer
- Megan McCrae — Senior VP of Corporate Strategy & International Growth
- Borna Zlamalik — Senior VP of Innovation and International R&D
- Bradley Gunter — Senior VP of Sales
- Steven Nazarian — Senior VP of Innovation and Product Development Engineering
- Geoffrey Machum — Director

## Questions

### How is Organigram structured as a corporate entity?

Organigram Global Inc. is a publicly traded company listed on the Toronto Stock Exchange, not a family office or private holding vehicle. It operates as a vertically integrated cannabis consumer packaged goods company, cultivating, extracting, manufacturing, and distributing branded products across Canada and through international supply agreements.

### Which sectors does Organigram Global explicitly focus on?

The firm concentrates entirely on regulated cannabis, covering flower, pre-rolls, edibles, vapes, extracts, and lozenges. Its portfolio includes value brands like SHRED, premium lines like Edison, and wellness-oriented products like Monjour. It does not operate outside cannabis or adjacent into broader consumer goods.

### Does Organigram Global participate in fund commitments or only direct operating investments?

Organigram invests directly in wholly owned operating subsidiaries and brands, not as a limited partner in external funds. Its corporate development strategy relies on acquisitions like the 2024 Motif Labs deal and structured international partnerships, rather than passive fund commitments or venture-style minority positions.

### What is Organigram's known posture on co-investments alongside external companies?

Organigram enters structured strategic agreements rather than blind-pool co-investment arrangements. Its 2023 agreements with Sanity Group, 4C Labs, and Phylos Bioscience are supply, licensing, and intellectual property partnerships, not co-investment vehicles. Each deal includes defined commercial terms for product distribution in specific non-Canadian jurisdictions.

### Where does Organigram's revenue come from geographically?

The firm's primary revenue engine is the Canadian adult-use market, served by its cultivation, extraction, and manufacturing facilities in New Brunswick, Quebec, Manitoba, and Ontario. International revenue channels are developing through its German and UK agreements, but the company has not disclosed the percentage of total revenue from non-Canadian sources.

## Related profiles

- [Bakkt Marketplace](https://altss.com/profile/bakkt-marketplace)
- [Momentum Venture Capital](https://altss.com/profile/momentum-venture-capital)

---

Last updated: 2026-08-11T15:07:41.444Z

Canonical page: https://altss.com/profile/organigram-holdings-inc

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology